Eintrag weiter verarbeiten
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination
Gespeichert in:
| Zeitschriftentitel: | Chemical Engineering & Technology |
|---|---|
| Personen und Körperschaften: | |
| In: | Chemical Engineering & Technology, 31, 2008, 6, S. 858-863 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Voß, C. Voß, C. |
|---|---|
| author |
Voß, C. |
| spellingShingle |
Voß, C. Chemical Engineering & Technology Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination Industrial and Manufacturing Engineering General Chemical Engineering General Chemistry |
| author_sort |
voß, c. |
| spelling |
Voß, C. 0930-7516 1521-4125 Wiley Industrial and Manufacturing Engineering General Chemical Engineering General Chemistry http://dx.doi.org/10.1002/ceat.200800069 <jats:title>Abstract</jats:title><jats:p>Plasmid DNA is used as a cloning vector to deliver recombinant genetic information into microorganisms. Since the 1990s, this principle has also been applied for the delivery of therapeutic genes in gene therapy and genetic vaccination. This non‐viral gene delivery is afflicted with fewer safety concerns in comparison to viral systems. Processes for the production of high‐quality plasmid DNA at multi‐ and kilogram scale are necessary to meet the needs of clinical trials as well as future therapeutics. Cell disruption, the separation of structurally‐related impurities and analytical techniques for process and quality control are the main challenges for bioengineering. This review summarizes the development in these fields over the past recent years.</jats:p> Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination Chemical Engineering & Technology |
| doi_str_mv |
10.1002/ceat.200800069 |
| facet_avail |
Online |
| finc_class_facet |
Technik |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9jZWF0LjIwMDgwMDA2OQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9jZWF0LjIwMDgwMDA2OQ |
| institution |
DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 |
| imprint |
Wiley, 2008 |
| imprint_str_mv |
Wiley, 2008 |
| issn |
0930-7516 1521-4125 |
| issn_str_mv |
0930-7516 1521-4125 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
voss2008downstreamprocessingofplasmiddnaforgenetherapyandgeneticvaccination |
| publishDateSort |
2008 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Chemical Engineering & Technology |
| source_id |
49 |
| title |
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_unstemmed |
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_full |
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_fullStr |
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_full_unstemmed |
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_short |
Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_sort |
downstream processing of plasmid dna for gene therapy and genetic vaccination |
| topic |
Industrial and Manufacturing Engineering General Chemical Engineering General Chemistry |
| url |
http://dx.doi.org/10.1002/ceat.200800069 |
| publishDate |
2008 |
| physical |
858-863 |
| description |
<jats:title>Abstract</jats:title><jats:p>Plasmid DNA is used as a cloning vector to deliver recombinant genetic information into microorganisms. Since the 1990s, this principle has also been applied for the delivery of therapeutic genes in gene therapy and genetic vaccination. This non‐viral gene delivery is afflicted with fewer safety concerns in comparison to viral systems. Processes for the production of high‐quality plasmid DNA at multi‐ and kilogram scale are necessary to meet the needs of clinical trials as well as future therapeutics. Cell disruption, the separation of structurally‐related impurities and analytical techniques for process and quality control are the main challenges for bioengineering. This review summarizes the development in these fields over the past recent years.</jats:p> |
| container_issue |
6 |
| container_start_page |
858 |
| container_title |
Chemical Engineering & Technology |
| container_volume |
31 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792345426214518784 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:23:18.493Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Downstream+Processing+of+Plasmid+DNA+for+Gene+Therapy+and+Genetic+Vaccination&rft.date=2008-06-01&genre=article&issn=1521-4125&volume=31&issue=6&spage=858&epage=863&pages=858-863&jtitle=Chemical+Engineering+%26+Technology&atitle=Downstream+Processing+of+Plasmid+DNA+for+Gene+Therapy+and+Genetic+Vaccination&aulast=Vo%C3%9F&aufirst=C.&rft_id=info%3Adoi%2F10.1002%2Fceat.200800069&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792345426214518784 |
| author | Voß, C. |
| author_facet | Voß, C., Voß, C. |
| author_sort | voß, c. |
| container_issue | 6 |
| container_start_page | 858 |
| container_title | Chemical Engineering & Technology |
| container_volume | 31 |
| description | <jats:title>Abstract</jats:title><jats:p>Plasmid DNA is used as a cloning vector to deliver recombinant genetic information into microorganisms. Since the 1990s, this principle has also been applied for the delivery of therapeutic genes in gene therapy and genetic vaccination. This non‐viral gene delivery is afflicted with fewer safety concerns in comparison to viral systems. Processes for the production of high‐quality plasmid DNA at multi‐ and kilogram scale are necessary to meet the needs of clinical trials as well as future therapeutics. Cell disruption, the separation of structurally‐related impurities and analytical techniques for process and quality control are the main challenges for bioengineering. This review summarizes the development in these fields over the past recent years.</jats:p> |
| doi_str_mv | 10.1002/ceat.200800069 |
| facet_avail | Online |
| finc_class_facet | Technik |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9jZWF0LjIwMDgwMDA2OQ |
| imprint | Wiley, 2008 |
| imprint_str_mv | Wiley, 2008 |
| institution | DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3 |
| issn | 0930-7516, 1521-4125 |
| issn_str_mv | 0930-7516, 1521-4125 |
| language | English |
| last_indexed | 2024-03-01T17:23:18.493Z |
| match_str | voss2008downstreamprocessingofplasmiddnaforgenetherapyandgeneticvaccination |
| mega_collection | Wiley (CrossRef) |
| physical | 858-863 |
| publishDate | 2008 |
| publishDateSort | 2008 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Chemical Engineering & Technology |
| source_id | 49 |
| spelling | Voß, C. 0930-7516 1521-4125 Wiley Industrial and Manufacturing Engineering General Chemical Engineering General Chemistry http://dx.doi.org/10.1002/ceat.200800069 <jats:title>Abstract</jats:title><jats:p>Plasmid DNA is used as a cloning vector to deliver recombinant genetic information into microorganisms. Since the 1990s, this principle has also been applied for the delivery of therapeutic genes in gene therapy and genetic vaccination. This non‐viral gene delivery is afflicted with fewer safety concerns in comparison to viral systems. Processes for the production of high‐quality plasmid DNA at multi‐ and kilogram scale are necessary to meet the needs of clinical trials as well as future therapeutics. Cell disruption, the separation of structurally‐related impurities and analytical techniques for process and quality control are the main challenges for bioengineering. This review summarizes the development in these fields over the past recent years.</jats:p> Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination Chemical Engineering & Technology |
| spellingShingle | Voß, C., Chemical Engineering & Technology, Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination, Industrial and Manufacturing Engineering, General Chemical Engineering, General Chemistry |
| title | Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_full | Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_fullStr | Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_full_unstemmed | Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_short | Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| title_sort | downstream processing of plasmid dna for gene therapy and genetic vaccination |
| title_unstemmed | Downstream Processing of Plasmid DNA for Gene Therapy and Genetic Vaccination |
| topic | Industrial and Manufacturing Engineering, General Chemical Engineering, General Chemistry |
| url | http://dx.doi.org/10.1002/ceat.200800069 |